Open access · Peer reviewed · No APCs
Case ReportJournal of Young PharmacistsVol. 15 | Issue 4 | 2023 | pp. 767–769Open access
The Cardiotoxic Effects of Remdesivir Administered to the Patients with SARS-CoV Infection Dharti Bhagat1 , Sefali Patel1 , Manoj Dikkatwar2 , Radhika Bindu1
- 1,
- 1,
- 2,
- 1*
- 1 Department of Pharmacy Practice, Parul University, Vadodara, Gujarat, INDIA.
- 2 Department of Pharmacy Practice, DY Patil University School of Pharmacy, Affiliated to DY Patil (Deemed to be University), Nerul, Navi Mumbai, Maharashtra, INDIA.
Published in Journal of Young Pharmacists
Correspondence: Radhika Bindu
Department of Pharmacy Practice, Parul University, Vadodara, Gujarat, INDIA.
Email: radhikasaddu94@gmail.com
Copyright: © 2023 Manuscript Technomedia. This is an open access article.
- Published:
- Dec 7, 2023
- Received:
- Apr 30, 2023
- Accepted:
- Jul 28, 2023
How to cite
Bhagat, D., Patel, S., Dikkatwar, M., & Bindu, R. (2023). The Cardiotoxic Effects of Remdesivir Administered to the Patients with SARS-CoV Infection Dharti Bhagat1 , Sefali Patel1 , Manoj Dikkatwar2 , Radhika Bindu1. Journal of Young Pharmacists, 15(4), 767–769. https://doi.org/10.5530/jyp.2023.15.107
Abstract
Coronavirus has become a pandemic without a reliable treatment since December 2019. The antiviral medication remdesivir, which also inhibits one of the most powerful viral RNA enzymes, RNA dependent RNA polymerase, prevents the SARS-CoV virus from reproducing. Cardiomyocytes can experience substantial cytotoxic effects from remdesivir. Remdesivir binds to human mitochondrial RNA polymerase, which causes cardiotoxicity. A prolonged QT interval and the emergence of torsade de pointes could result from lengthening the field potential duration while lowering the amplitude of the Na+ peak and the pace of spontaneous beating in a dose-dependent way. The current safety profile of Remdesivir is not yet completely established, and it is necessary to evaluate the safety profile and any potential adverse cardiovascular consequences by conducting additional clinical trials. In this case report, adverse effects of remdesivir to assess its safety profile in Covid-19 patients is reviewed.
Keywords
Subject
Article metadata
| Title | The Cardiotoxic Effects of Remdesivir Administered to the Patients with SARS-CoV Infection Dharti Bhagat1 , Sefali Patel1 , Manoj Dikkatwar2 , Radhika Bindu1 |
|---|---|
| Authors | Dharti Bhagat; Sefali Patel; Manoj Dikkatwar; Radhika Bindu |
| Affiliations | Department of Pharmacy Practice, Parul University, Vadodara, Gujarat, INDIA.; Department of Pharmacy Practice, DY Patil University School of Pharmacy, Affiliated to DY Patil (Deemed to be University), Nerul, Navi Mumbai, Maharashtra, INDIA. |
| Corresponding author | radhikasaddu94@gmail.com |
| Journal | Journal of Young Pharmacists |
| Volume / Issue | Vol. 15, Issue 4 (2023) |
Also in this issue
- Nanoparticulate Formulation for the Treatment of Different Types of Colon Disease Like Ulcerative Colitis: A Comprehensive Reviewpp. 585–588
- A Comprehensive Overview of Edible Natural Excipients and their Potential Use in Pharmaceutical Formulation Developmentpp. 589–594
- Nutraceuticals: Regulatory Landscape and Market Dynamics in the Indian Scenariopp. 595–603
- Phytoextract Loaded Nanoemulsions for Age-Defying Effects: A Reviewpp. 604–615
- Analysis of Mortality, Morbidity, and the Provision of Pharmaceutical Care Services in Intensive Care Admitted Patients–An Overviewpp. 616–621
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026